AWARE - Chronic Urticaria

CompletedOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

September 3, 2014

Primary Completion Date

September 27, 2017

Study Completion Date

September 27, 2017

Conditions
Chronic Urticaria
Trial Locations (21)

PL6 8DH

Novartis Investigative Site, Plymouth

DL3 6HX

Novartis Investigative Site, Darlington

E11 1NR

Novartis Investigative Site, Leytonstone

M6 8HD

Novartis Investigative Site, Salford

CV2 2DX

Novartis Investigative Site, Coventry

BT12 6BA

Novartis Investigative Site, Belfast

BT9 7AB

Novartis Investigative Site, Belfast

CF14 4XW

Novartis Investigative Site, Cardiff

CH2 1UL

Novartis Investigative Site, Chester

DH1 6TW

Novartis Investigative Site, Durham

HU16 5JQ

Novartis Investigative Site, East Yorkshire

CT9 4AN

Novartis Investigative Site, Kent

LS9 7PN

Novartis Investigative Site, Leeds

LE1 5WW

Novartis Investigative Site, Leicester

L14 3PE

Novartis Investigative Site, Liverpool

SE18 4QH

Novartis Investigative Site, London

M13 9WL

Novartis Investigative Site, Manchester

M23 9LT

Novartis Investigative Site, Manchester

TS4 3BW

Novartis Investigative Site, Middlesbrough

BH15 2JB

Novartis Investigative Site, Poole

S5 7AU

Novartis Investigative Site, Sheffield

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY